Pharmidex attending the Global Business Accelerator visit to Switzerland
March 10, 2018

Pharmidex will be attending the Global Business Accelerator Program which is run by the Enterprise Europe Network and supported by Innovate UK.

The Enterprise Europe Network, supported by Innovate UK, are visiting Switzerland to focus on the pharmaceutical technology industry. The chosen companies will have the opportunity to meet pharmaceutical companies and key stakeholders based in Basel and attend ProcureCon Pharma in Zürich for the next three days


The Swiss pharmaceutical sector is a major employer with more than 40,000 people working directly for the industry. If the indirect work created through ancillary industries is included, as many as 172,000 jobs are related to the pharmaceutical industry. In addition, it accounts for up to a third of all Swiss exports, and the productivity of the industry is four times as high as that of the economy as a whole.


Three big clusters – the Lake Geneva area, the Basel region and Zürich-Zug-Lucerne – account for the lion’s share of the gross value added of the Swiss pharmaceutical industry and present many collabartive opputunities for UK companies. 


During the trip Pharmidex will also be attending ProcureCon Pharma, organised by Worldwide Business Research, will take place from 13 to 15 March 2018 in Zürich. Delegates will have the opportunity to join 200 senior procurement professionals from Merck, Astra Zeneca, Roche, Sanofi, Lonza and other world-leading pharmaceutical businesses over three days. 


We look forward to meeting you there.

May 12, 2026
Pharmidex is pleased to announce that Ash Alavijeh , will be attending Bio Integrates 2026 on 14 May 2026 at Victoria House, Bloomsbury, London. Ash looks forward to meeting founders, investors, biotech leaders and scientific partners to discuss drug discovery, translational development and new opportunities across the life sciences sector. He will be delighted to connect with attendees and explore new collaborations and partnerships in the drug development field, feel free to catch him for a chat!
May 11, 2026
We are delighted to welcome Yvonne Squire to the Pharmidex team as our new Senior Histologist. Yvonne brings over 15 years of experience in non-clinical histology and toxicology, with expertise in necropsy, tissue preparation, histochemical techniques and GLP-compliant laboratory operations. Her experience will further strengthen Pharmidex’s histology and translational research capabilities. Welcome to Pharmidex, Yvonne!
May 7, 2026
We are delighted to announce and congratulate Ash Alavijeh on his appointment as Chief Operating Officer at Pharmidex . Ash has been an integral part of Pharmidex’s journey, bringing strong leadership, strategic vision and a deep commitment to advancing our capabilities in drug discovery and development. In his new role as COO, he will play a key part in driving operational excellence and supporting the continued growth of the company. This appointment reflects both Ash’s contributions to date and our confidence in his leadership as we continue to expand and evolve. Please join us in congratulating Ash on this well-deserved achievement.
More Posts